Dynachem Pharmaceuticals (Exports)Ltd Profile
Key Indicators
- Authorised Capital ₹ 12.00 Cr
as on 03-01-2025
- Paid Up Capital ₹ 11.58 Cr
as on 03-01-2025
- Company Age 32 Year, 1 Month
- Last Filing with ROC 31 Mar 2018
About Dynachem Pharmaceuticals (Exports)Ltd
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 12.00 Cr and a paid-up capital of Rs 11.58 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vimalkumar Raval, Panchal Laxmanbhai, and Tejashree Jadhav serve as directors at the Company.
- CIN/LLPIN
U24231GJ1992PLC018677
- Company No.
018677
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
11 Dec 1992
- Date of AGM
31 Aug 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dynachem Pharmaceuticals (Exports)Ltd?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vimalkumar Raval  | Additional Director | 08-Aug-2017 | Current |
| Panchal Laxmanbhai | Additional Director | 08-Aug-2017 | Current |
| Tejashree Jadhav | Additional Director | 08-Aug-2017 | Current |
Financial Performance of Dynachem Pharmaceuticals (Exports)Ltd.
Dynachem Pharmaceuticals (Exports)Ltd, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Dynachem Pharmaceuticals (Exports)Ltd?
In 2017, Dynachem Pharmaceuticals (Exports)Ltd had a promoter holding of 25.56% and a public holding of 74.44%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Sunbright Stock Broking LimitedActive 30 years 5 months
Vimalkumar Raval and Tejashree Jadhav are mutual person
- Sonal Cosmetics (Exports) LimitedActive 32 years 9 months
Vimalkumar Raval, Panchal Laxmanbhai and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dynachem Pharmaceuticals (Exports)Ltd?
Unlock and access historical data on people associated with Dynachem Pharmaceuticals (Exports)Ltd, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dynachem Pharmaceuticals (Exports)Ltd, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dynachem Pharmaceuticals (Exports)Ltd's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
